Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Emodin improves lipopolysaccharide-induced microcirculatory disturbance in rat mesentery.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9434935 Publication Model: Print Cited Medium: Internet ISSN: 1549-8719 (Electronic) Linking ISSN: 10739688 NLM ISO Abbreviation: Microcirculation Subsets: MEDLINE
- Publication Information:
Publication: Malden, MA : Wiley-Blackwell
Original Publication: New York, NY : Chapman & Hall, c1994-
- Subject Terms:
- Abstract:
Objective: Sepsis is a systemic inflammatory response syndrome. Emodin is a major ingredient of Rheum Palmatum, a Chinese herb that is widely used in China for treatment of endotoxemia-related diseases. This study intended to examine the effect of Emodin on LPS-induced rat mesenteric microcirculatory disturbance and the underlying mechanisms.
Methods: The male Wistar rats received LPS (5 mg/kg/hr) for 90 min, with or without administration of Emodin (10 mg/kg/hr) by enema 30 min before (pre-treatment) or after (post-treatment) LPS infusion, and the dynamics of mesenteric microcirculation were determined by inverted intravital microscopy. Expression of adhesion molecules and TLR4, NF-κB p65, ICAM-1, MPO, and AP-1 in mesentery tissue was evaluated by flow cytometry and Western-blot, respectively.
Results: Pre or post-treatment with Emodin significantly ameliorated LPS-induced leukocyte emigration, reactive oxygen species production and albumin leakage, and the expression of TLR4, NF-κB p65, ICAM-1, MPO and AP-1 in mesentery.
Conclusions: These results demonstrate the beneficial role of Emodin in attenuating the LPS-induced microcirculatory disturbance, and support the use of Emodin for patients with endotoxemia.
(© 2013 John Wiley & Sons Ltd.)
- Contributed Indexing:
Keywords: Rheum palmatum; activator protein-1; adhesion molecules; nuclear factor kappa B p65; toll-like receptor 4
- Accession Number:
0 (Lipopolysaccharides)
0 (Protein Kinase Inhibitors)
0 (Rela protein, rat)
0 (Tlr4 protein, rat)
0 (Toll-Like Receptor 4)
0 (Transcription Factor AP-1)
0 (Transcription Factor RelA)
126547-89-5 (Intercellular Adhesion Molecule-1)
EC 1.11.1.7 (Peroxidase)
KA46RNI6HN (Emodin)
- Publication Date:
Date Created: 20130405 Date Completed: 20140430 Latest Revision: 20131014
- Publication Date:
20231215
- Accession Number:
10.1111/micc.12061
- Accession Number:
23551520
No Comments.